{"brief_title": "Multicenter Clinical Trial of Buprenorphine - 3", "brief_summary": "The purpose of this study is to test the efficacy and safety of buprenorphine.", "detailed_description": "12 different sites for a total of 736 subjects (60 at Pizarro, 70 at West LA Tx center, 15 in the 1 year extension)", "condition": ["Opioid-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Buprenorphine"], "criteria": "Inclusion Criteria: M/F, ages 21-50. opiate dependence according to DSM-IV criteria. Self-reported use within the last 30 days. Agreeable to conditions of the study and signed informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.", "gender": "All", "minimum_age": "21 Years", "maximum_age": "50 Years", "healthy_volunteers": "No", "keyword": "Opioid", "mesh_term": ["Opioid-Related Disorders", "Buprenorphine"], "id": "NCT00000207"}